We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.
Fig 1.

Fig 1. From: Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?.

Updated trends in the aggressiveness of cancer care near the end of life, all cancer types, all durations of disease among 215,484 Medicare enrollees in Surveillance, Epidemiology, and End Results (SEER) areas who died as a result of cancer. (*) Among patients admitted to hospice. (†) Among patients who received chemotherapy. ER, emergency room; ICU, intensive care unit.

Craig C. Earle, et al. J Clin Oncol. 2008 August 10;26(23):3860-3866.
2.
Fig 2.

Fig 2. From: Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?.

Maps showing distribution of aggressive chemotherapy use and hospice underutilization among 215,484 Medicare enrollees in Surveillance, Epidemiology, and End Results (SEER) Health Care Service Areas (HSCAs) who died as a result of cancer between 1991 and 2000. Gray HCSAs were ranked in the top 25 of 77 HCSAs monitored by SEER every year for 10 years, blue HCSAs were ranked in the bottom 25, and the rest are indicated by yellow. White HCSAs are those not monitored by the SEER program.

Craig C. Earle, et al. J Clin Oncol. 2008 August 10;26(23):3860-3866.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk